We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editorial |

Contactin-Associated Protein-like 2 Antibodies Tackling the Issue of Syndrome Diversity

Christian G. Bien, MD1
[+] Author Affiliations
1Epilepsy Centre Bethel, Krankenhaus Mara, Bielefeld, Germany
JAMA Neurol. 2016;73(9):1058-1059. doi:10.1001/jamaneurol.2016.1739.
Text Size: A A A
Published online


In 2007, the detection of IgG antibodies against the N-methyl-d-aspartate receptor in young women with encephalopathy opened a new field in neurology: the study of encephalitides with antibodies directed against well-defined antigens on the surfaces of central nervous system neurons.1 In 2010, the Oxford Neuroimmunology Group detected contactin-associated protein-like 2 (CASPR2) antibodies as one of the next antigenic targets of presumably pathogenic IgG antibodies.2 Unlike the N-methyl-d-aspartate receptor and most of the other antigens on neural surfaces, CASPR2 is not a receptor but associates with voltage-gated potassium channels at the juxtaparanodes of myelinated axons. Together with TAG-1, CASPR2 forms a scaffold beneath the myelin sheath, which enables a clustering of those channels. This is required for the proper electrical function of the neurons.3 Until recently, to my knowledge, no more than 50 patients with CASPR2 antibody–associated syndromes were reported in dedicated series.2,46 Patients were diagnosed as having limbic encephalitis (LE), peripheral nerve hyperexcitability (neuromyotonia), a combination of central nervous system symptoms and neuromyotonia (Morvan syndrome), or ataxia.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles